<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><front><journal-meta><journal-id journal-id-type="nlm-ta">Complement Ther Clin Pract</journal-id><journal-id journal-id-type="iso-abbrev">Complement Ther Clin Pract</journal-id><journal-title-group><journal-title>Complementary Therapies in Clinical Practice</journal-title></journal-title-group><issn pub-type="ppub">1744-3881</issn><issn pub-type="epub">1873-6947</issn><publisher><publisher-name>Elsevier Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7415165</article-id><article-id pub-id-type="publisher-id">S1744-3881(20)31102-6</article-id><article-id pub-id-type="doi">10.1016/j.ctcp.2020.101227</article-id><article-id pub-id-type="publisher-id">101227</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Propolis and coronavirus disease 2019 (COVID-19): Lessons from nature</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Scorza</surname><given-names>Carla A.</given-names></name></contrib><contrib contrib-type="author" id="au2"><name><surname>Gon&#x000e7;alves</surname><given-names>Valeria C.</given-names></name></contrib><contrib contrib-type="author" id="au3"><name><surname>Scorza</surname><given-names>Fulvio A.</given-names></name><email>scorza@unifesp.br</email><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><aff id="aff1">Disciplina de Neuroci&#x000ea;ncia, Escola Paulista de Medicina/Universidade Federal de S&#x000e3;o Paulo (EPM/UNIFESP), S&#x000e3;o Paulo, Brazil</aff></contrib-group><contrib-group><contrib contrib-type="author" id="au4"><name><surname>Fiorini</surname><given-names>Ana C.</given-names></name></contrib><aff id="aff2">Departamento de Fonoaudiologia, Escola Paulista de Medicina/Universidade Federal de S&#x000e3;o Paulo (EPM/UNIFESP), S&#x000e3;o Paulo, Brazil</aff><aff id="aff3">Programa de Estudos P&#x000f3;s-Graduado Em Fonoaudiologia, Pontif&#x000ed;cia Universidade Cat&#x000f3;lica de S&#x000e3;o Paulo (PUC-SP), S&#x000e3;o Paulo, Brazil</aff></contrib-group><contrib-group><contrib contrib-type="author" id="au5"><name><surname>de Almeida</surname><given-names>Antonio-Carlos G.</given-names></name></contrib><aff id="aff4">Laborat&#x000f3;rio de Neuroci&#x000ea;ncia Experimental e Computacional, Departamento de Engenharia de Biossistemas, Universidade Federal de S&#x000e3;o Jo&#x000e3;o Del-Rei (UFSJ), Brazil</aff></contrib-group><contrib-group><contrib contrib-type="author" id="au6"><name><surname>Fonseca</surname><given-names>Marcelo C.M.</given-names></name></contrib><aff id="aff5">Departamento de Ginecologia, N&#x000fa;cleo de Avalia&#x000e7;&#x000e3;o de Tecnologias Em Sa&#x000fa;de, Escola Paulista de Medicina/Universidade Federal de S&#x000e3;o Paulo (EPM/UNIFESP), S&#x000e3;o Paulo, Brazil</aff></contrib-group><contrib-group><contrib contrib-type="author" id="au7"><name><surname>Finsterer</surname><given-names>Josef</given-names></name></contrib><aff id="aff6">Krankenanstalt Rudolfstiftung, Messerli Institute, Vienna, Austria</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. Rua Pedro de Toledo, 669 &#x02013; 10 andar, CEP: 04039-032, S&#x000e3;o Paulo, SP, Brazil. <email>scorza@unifesp.br</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>9</day><month>8</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>11</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>9</day><month>8</month><year>2020</year></pub-date><volume>41</volume><fpage>101227</fpage><lpage>101227</lpage><history><date date-type="received"><day>22</day><month>6</month><year>2020</year></date><date date-type="rev-recd"><day>19</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>4</day><month>8</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Elsevier Ltd. All rights reserved.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Elsevier Ltd</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions></article-meta></front><body><p id="p0010">Always on the lookout for articles from the journal Complementary Therapies in Clinical Practice one in particular has attracted a lot of attention due the eminent clinical importance of this study. Very recent, Xu and Zhang published an excellent review article clearly demonstrating that the intervention of traditional Chinese medicine can reduce severe symptoms of patients with the new coronavirus (SARS-Cov-2) [<xref rid="bib1" ref-type="bibr">1</xref>]. Considering that there is no standard therapy for SARS-Cov-2 prevention or treatment, we would like to add some thoughts that may open the debate about the possible viability of propolis in this situation.</p><p id="p0015">SARS-Cov-2 which hit the central Chinese city of Wuhan in late December 2019, and subsequently spread rapidly to all provinces of China and all countries worldwide, has had a devastating impact on global public health [<xref rid="bib2" ref-type="bibr">2</xref>]. SARS-Cov-2 is characterized by a high contagiousness. In 85% of cases it causes subclinical or mild disease, but compared to the flu it more easily causes respiratory complications (e.g., severe pneumonia (ground glass opacities) and interstitial pneumonia) in 10&#x02013;15% of cases. 5% of infected patients require ICU admission [<xref rid="bib2" ref-type="bibr">2</xref>]. During these worst-case scenarios, lethality is estimated at around 0.7&#x02013;7% [<xref rid="bib2" ref-type="bibr">2</xref>,<xref rid="bib3" ref-type="bibr">3</xref>]. Compared to previous coronavirus epidemics, the contagiousness is higher, but the mortality decidedly lower compared to the <italic>severe acute respiratory syndrome</italic> (SARS) of 2002 and the <italic>Middle East respiratory syndrome</italic> (MERS) of 2012, both of them related with higher mortality (9.5% and 34.4%, respectively) [<xref rid="bib2" ref-type="bibr">2</xref>,<xref rid="bib3" ref-type="bibr">3</xref>]. Intensely, a series of translational studies for drug and vaccine development has been carried out worldwide with the aim of combating the SARS-Cov-2 [<xref rid="bib4" ref-type="bibr">4</xref>]. In these lines, medicinal plants and the pure natural molecules isolated from plants has shown an important inhibitory antiviral activity against SARS-Cov-2 [<xref rid="bib4" ref-type="bibr">4</xref>]. From this clinical reasoning, the use of propolis as a possible complementary treatment in patients with SARS-Cov-2 should play an important role in this scenario.</p><p id="p0020">Although nature has served as a source of healing since evolution of mankind, nature is also inspiring the next generation of biomedical research and technology [<xref rid="bib5" ref-type="bibr">5</xref>,<xref rid="bib6" ref-type="bibr">6</xref>]. Despite this fact, it is also important to note that not all physicians and researchers are prepared to deepen their knowledge about biomimicry, probably because of a lack of exposure to biomimicry during training [<xref rid="bib7" ref-type="bibr">7</xref>]. Biomimicry (from the Greek words <italic>bios</italic>, meaning &#x0201c;life,&#x0201d; and <italic>mimesis</italic>, meaning &#x0201c;to imitate&#x0201d;) it is an area of science that studies nature's models and then emulates these forms, processes, systems, and strategies to solve human problems [<xref rid="bib5" ref-type="bibr">[5]</xref>, <xref rid="bib6" ref-type="bibr">[6]</xref>, <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib8" ref-type="bibr">[8]</xref>]. According to experts, biomimicry is based not on what we can extract from organisms and their ecosystems, but on what we can learn from them [<xref rid="bib6" ref-type="bibr">6</xref>,<xref rid="bib7" ref-type="bibr">7</xref>]. Regarding our proposal on propolis, it is already established in the literature that one of the ways that honey bees&#x02019; colonies maintain health and immunity is for the formation of a propolis envelope within the nest that acts as an important antimicrobial layer [<xref rid="bib9" ref-type="bibr">9</xref>]. Following these reasonings, what would be the benefit of propolis in SARS-Cov-2?</p><p id="p0025">Propolis is defined as a balsamic and resinous product composed of a mixture of different plant parts and molecules secreted by bees [<xref rid="bib10" ref-type="bibr">10</xref>]. Importantly, propolis is used by humans since ancient times for its medicinal properties [<xref rid="bib11" ref-type="bibr">11</xref>]. As a natural compound with proven pharmacological and pharmaceutical properties, propolis has actually a wide application, with antioxidant, antimicrobial, antiviral, antiparasitic, antitumor, immunomodulatory, anti-inflammatory and hepatoprotective properties [<xref rid="bib10" ref-type="bibr">10</xref>,<xref rid="bib12" ref-type="bibr">12</xref>]. Thus, these different therapeutic effects of propolis justify its potential for the development of products for use in human and animal health [<xref rid="bib10" ref-type="bibr">10</xref>]. Concerning the use of propolis in SARS-Cov-2-infected patients, some interesting considerations must be put forward.</p><p id="p0030">Firstly, several experimental and clinical studies have clearly shown that propolis extracts from temperate climate presents a potent and broad-spectrum antiviral activity against a diverse panel of viruses, including HSV-1, HSV-2, Influenza virus type A and B, Parainfluenza virus, Adenovirus, HIV, infectious bursal disease virus and avian reovirus, Newcastle virus disease, bovine rotavirus, pseudorabies virus, feline calicivirus, canine adenovirus type 2, and bovine viral diarrhea virus [<xref rid="bib11" ref-type="bibr">11</xref>]. The precise mechanisms of this antiviral activity is unknown, however, it is very likely that propolis inhibits the virus entry into the cells, and with that disrupt the viral replication machinery [<xref rid="bib11" ref-type="bibr">11</xref>]. Concerning SARS-Cov-2, studies with propolis are still rare but those available are quite promising [<xref rid="bib11" ref-type="bibr">11</xref>]. Three decades ago, <italic>in vitro</italic> studies evaluated the effect of propolis flavonoids on several DNA and RNA viruses, including coronavirus [<xref rid="bib11" ref-type="bibr">11</xref>,<xref rid="bib13" ref-type="bibr">13</xref>]. The authors found that chrysin and kaempferol were highly active in inhibiting viral replication [<xref rid="bib11" ref-type="bibr">11</xref>,<xref rid="bib13" ref-type="bibr">13</xref>]. Another important propolis flavonoid applied in SARS research is quercetin [<xref rid="bib11" ref-type="bibr">11</xref>,<xref rid="bib14" ref-type="bibr">14</xref>]. In these terms, it has been demonstrated that quercetin in conjunction with vitamin C shows aminopeptidase inhibitor activity, interrupting the main proteases of SARS and MERS [<xref rid="bib11" ref-type="bibr">11</xref>,<xref rid="bib14" ref-type="bibr">14</xref>].</p><p id="p0035">On the whole, due to the recent SARS-Cov-2 pandemic, studies with propolis can be considered very promising. Thus, our research group is totally convinced of the broad action of propolis in the various biological systems [<xref rid="bib15" ref-type="bibr">15</xref>]. Finally, the safety, health effects, low cost, and easy use make propolis an intriguing supportive therapy for SARS-Cov-2.</p></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Xu</surname></name><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group><article-title>Traditional Chinese medicine treatment of COVID-19</article-title><source>Compl. Ther. Clin. Pract.</source><volume>39</volume><year>2020</year><fpage>101165</fpage></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Di Pasquale</surname><given-names>G.</given-names></name></person-group><article-title>COVID-19 coronavirus: what implications for Cardiology?</article-title><source>G. Ital. Cardiol.</source><volume>21</volume><year>2020</year><fpage>243</fpage><lpage>245</lpage></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Lu</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name></person-group><article-title>Clinical observation and management of COVID-19 patients</article-title><source>Emerg. Microb. Infect.</source><volume>9</volume><year>2020</year><fpage>687</fpage><lpage>690</lpage></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Orhan</surname><given-names>I.E.</given-names></name><name><surname>Senol Deniz</surname><given-names>F.S.</given-names></name></person-group><article-title>Natural products as potential leads against coronaviruses: could they be encouraging structural models against SARS-CoV-2?</article-title><source>Nat. Prod. Bioprospect.</source><year>2020</year><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">32016770</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="other" id="sref5"><article-title>What is biomimicry?</article-title><comment>Available at:</comment><ext-link ext-link-type="uri" xlink:href="http://www.biomimicryinstitute.org/about-us/what-is-biomimicry.html" id="intref0010">http://www.biomimicryinstitute.org/about-us/what-is-biomimicry.html</ext-link></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="other" id="sref6"><article-title>What do you mean by the term biomimicry? A conversation with Janine Benyus, author of Biomimicry: innovation inspired by in nature</article-title><comment>Available at:</comment><ext-link ext-link-type="uri" xlink:href="http://www.biomimicryinstitute.org/about-us/what-is-biomimicry.html" id="intref0015">http://www.biomimicryinstitute.org/about-us/what-is-biomimicry.html</ext-link></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Scorza</surname><given-names>F.A.</given-names></name><name><surname>Cavalheiro</surname><given-names>E.A.</given-names></name></person-group><article-title>Biomimicry: applying design for nature to solve problems in epilepsy research</article-title><source>Epilepsy Behav.</source><volume>18</volume><year>2010</year><fpage>327</fpage><lpage>328</lpage><pub-id pub-id-type="pmid">20570217</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="book" id="sref8"><person-group person-group-type="author"><name><surname>Benyus</surname><given-names>J.M.</given-names></name></person-group><chapter-title>Biomimicry: Innovation Inspired by Nature</chapter-title><year>2002</year><publisher-name>Perennial</publisher-name><publisher-loc>New York</publisher-loc><comment>2002</comment></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Simone-Finstrom</surname><given-names>M.</given-names></name><name><surname>Borba</surname><given-names>R.S.</given-names></name><name><surname>Wilson</surname><given-names>M.</given-names></name><name><surname>Spivak</surname><given-names>M.</given-names></name></person-group><article-title>Propolis counteracts some threats to honey bee health</article-title><source>Insects</source><volume>8</volume><year>2017</year><fpage>46</fpage></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>L.M.</given-names></name><name><surname>Fonseca</surname><given-names>M.S.</given-names></name><name><surname>Sokolonski</surname><given-names>A.R.</given-names></name><name><surname>Deegan</surname><given-names>K.R.</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>R.P.</given-names></name><name><surname>Umsza-Guez</surname><given-names>M.A.</given-names></name></person-group><article-title>Propolis: types, composition, biological activities, and veterinary product patent prospecting</article-title><source>J. Sci. Food Agric.</source><volume>100</volume><year>2020</year><fpage>1369</fpage><lpage>1382</lpage><pub-id pub-id-type="pmid">31487405</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="book" id="sref11"><person-group person-group-type="author"><name><surname>Bachevski</surname><given-names>D.</given-names></name><name><surname>Damevska</surname><given-names>K.</given-names></name><name><surname>Simeonovski</surname><given-names>V.</given-names></name><name><surname>Dimova</surname><given-names>M.</given-names></name></person-group><chapter-title>Back to the Basics: Propolis and COVID-19</chapter-title><year>2020</year><publisher-name>Dermatol Ther</publisher-name><pub-id pub-id-type="doi">10.1111/dth.13780</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Braakhuis</surname><given-names>A.</given-names></name></person-group><article-title>Evidence on the health benefits of supplemental propolis</article-title><source>Nutrients</source><volume>11</volume><year>2019</year><fpage>2705</fpage></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Debiaggi</surname><given-names>M.</given-names></name><name><surname>Tateo</surname><given-names>F.</given-names></name><name><surname>Pagani</surname><given-names>L.</given-names></name><name><surname>Luini</surname><given-names>M.</given-names></name><name><surname>Romero</surname><given-names>E.</given-names></name></person-group><article-title>Effects of propolis flavonoids on virus infectivity and replication</article-title><source>Microbiol.</source><volume>13</volume><year>1990</year><fpage>207</fpage><lpage>213</lpage></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Syed</surname><given-names>S.</given-names></name><name><surname>Saleem</surname><given-names>A.</given-names></name></person-group><article-title>Severe acute respiratory syndrome epidemiology and control</article-title><source>Lab. Med.</source><volume>35</volume><year>2004</year><fpage>112</fpage><lpage>116</lpage></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Gon&#x000e7;alves</surname><given-names>V.C.</given-names></name><name><surname>Pinheiro</surname><given-names>D.J.L.L.</given-names></name><name><surname>de la Rosa</surname><given-names>T.</given-names></name><name><surname>de Almeida</surname><given-names>A.G.</given-names></name><name><surname>Scorza</surname><given-names>F.A.</given-names></name><name><surname>Scorza</surname><given-names>C.A.</given-names></name></person-group><article-title>Propolis as A Potential disease-modifying strategy in Parkinson's disease: cardioprotective and neuroprotective effects in the 6-OHDA rat model</article-title><source>Nutrients</source><volume>12</volume><year>2020</year><fpage>E1551</fpage><pub-id pub-id-type="pmid">32466610</pub-id></element-citation></ref></ref-list><ack id="ack0010"><title>Acknowledgements</title><p>Our studies are supported by the following grants: <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100001807</institution-id><institution>FAPESP (Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo)</institution></institution-wrap></funding-source>; <funding-source id="gs2"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100003593</institution-id><institution>CNPq (Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico)</institution></institution-wrap></funding-source> e <funding-source id="gs3"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100002322</institution-id><institution>Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior (CAPES)</institution></institution-wrap></funding-source>.</p></ack></back></article>